Elizabeth Harvey-Jones

Royal Marsden NHS Foundation Trust — United Kingdom

Biochemistry, Genetics and Molecular Biology · Life Sciences

8h-index2.5kcitations16works18.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

BRCA gene mutations in cancer(4), DNA Repair Mechanisms(3), Cancer Genomics and Diagnostics(3), PARP inhibition in cancer therapy(3), Advanced Breast Cancer Therapies(3)

Publications16 total

Advances in Colorectal Cancer Cell Biology and Clonal Evolution
International Journal of Molecular Sciences·2026Open Access
Abstract RF01-05: Functional assessment of RAD51 foci and replication fork dynamics in PARPi resistant BRCA1/2 mutated breast cancer
Cancer Research·2024
Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancer
Annals of Oncology·2024· 55 citedOpen Access
Renal replacement and extracorporeal therapies in critical care: current and future directions
Acute Medicine Journal·2023· 2 citedOpen Access
Abstract 6094: Longitudinal analysis of PARP inhibitor and platinum resistance in <i>BRCA1/2m</i> breast cancer using liquid biopsy
Cancer Research·2023· 4 cited
Systemic Therapy for Hereditary Breast Cancers
Hematology/Oncology Clinics of North America·2022· 5 citedOpen Access
Real-world outcomes associated with new cancer medicines approved by the Food and Drug Administration and European Medicines Agency: A retrospective cohort study
European Journal of Cancer·2021· 45 citedOpen Access
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
The Lancet Oncology·2021· 608 citedOpen Access
Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority guidelines
2021· 60 citedOpen Access
Abstract PS7-83: Outcomes and risk factors associated with breast cancer in women aged 35 and under: Single centre retrospective analysis
Cancer Research·2021
The impact of national non-pharmaceutical interventions (‘lockdowns’) on the presentation of cancer patients
ecancermedicalscience·2021· 41 citedOpen Access
Mortality due to cancer treatment delay: systematic review and meta-analysis
BMJ·2020· 1.6k citedOpen Access
Does Concurrent Use of CDK4/6 Inhibitors During Palliative Radiotherapy Increase Toxicity in Patients with Metastatic Breast Cancer?
International Journal of Radiation Oncology*Biology*Physics·2020· 1 cited
Does Concurrent Use of CDK4/6 Inhibitors During Palliative Radiotherapy Increase Toxicity in Patients With Metastatic Breast Cancer?
Clinical Oncology·2020· 14 cited
Safety and Efficacy of Pazopanib Therapy Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer
JAMA Oncology·2016· 78 cited
Baynes and Dominiczak's medical biochemistry flash cards
Annals of Clinical Biochemistry International Journal of Laboratory Medicine·2013

Frequent Co-authors

Thanussuyah Alaguthurai(5), Angela Swampillai(4), Christopher J. Lord(4), Andrew Tutt(4), Richard Sullivan(3), Ajay Aggarwal(3), Anne Rigg(3), Maya Raghunandan(3), Luisa Robbez‐Masson(3), Chris Starling(3), Rebecca Marlow(3), Ioannis Roxanis(3), Stephen J. Pettitt(3), Joanna Dodkins(3), Christopher M. Booth(2), Leticia Monin(2), Adam G. Laing(2), Miguel Muñoz‐Ruiz(2), Duncan R. McKenzie(2), Irene del Molino del Barrio(2)